Rabbit Polyclonal KLHL13 antibody. N-terminal. Suitable for WB and reacts with Human samples. Immunogen corresponding to Recombinant Fragment Protein within Human KLHL13.
pH: 7
Preservative: 0.01% Thimerosal (merthiolate)
Constituents: 20% Glycerol (glycerin, glycerine), 1.21% Tris, 0.75% Glycine
WB | |
---|---|
Human | Tested |
Mouse | Predicted |
Cow | Predicted |
Species | Dilution info | Notes |
---|---|---|
Species Human | Dilution info 1/500.00000 - 1/3000.00000 | Notes - |
Species | Dilution info | Notes |
---|---|---|
Species Mouse, Cow | Dilution info - | Notes - |
Substrate-specific adapter of a BCR (BTB-CUL3-RBX1) E3 ubiquitin-protein ligase complex required for mitotic progression and cytokinesis. The BCR(KLHL9-KLHL13) E3 ubiquitin ligase complex mediates the ubiquitination of AURKB and controls the dynamic behavior of AURKB on mitotic chromosomes and thereby coordinates faithful mitotic progression and completion of cytokinesis.
BKLHD2, KIAA1309, KLHL13, Kelch-like protein 13, BTB and kelch domain-containing protein 2
Rabbit Polyclonal KLHL13 antibody. N-terminal. Suitable for WB and reacts with Human samples. Immunogen corresponding to Recombinant Fragment Protein within Human KLHL13.
pH: 7
Preservative: 0.01% Thimerosal (merthiolate)
Constituents: 20% Glycerol (glycerin, glycerine), 1.21% Tris, 0.75% Glycine
KLHL13 also known as Kelch-like protein 13 participates in several mechanical processes within the cell. It has a mass of approximately 68 kDa. The protein operates as a member of the Kelch-like (KLHL) family which typically functions in ubiquitin-proteasome pathways. KLHL13 is widely expressed in numerous tissues including the brain heart and skeletal muscle indicating its role in diverse physiological functions.
KLHL13 interacts with other proteins to form complexes that regulate cellular processes. It often acts as a substrate adaptor in the Cullin-RING E3 ubiquitin ligase complex. This complex targets specific proteins for degradation maintaining protein homeostasis within the cell. KLHL13 thereby influences various cellular occurrences such as signal transduction and cell cycle control by dictating protein turnover rates.
KLHL13 impacts several critical biological pathways involved in cellular maintenance and signaling. Its activity is closely tied to the ubiquitin-proteasome pathway where it ensures the degradation of proteins that could alter cell function if accumulated. KLHL13 also shares functional relationships with other Kelch-like family members emphasizing its role in a network where different family proteins can have overlapping and distinct targets.
KLHL13's association with ubiquitin-proteasome pathways links it to neurological disorders such as Parkinson's disease. Abnormal protein degradation in these contexts can lead to protein aggregation and cellular dysfunction. It also relates to certain cancers where dysregulation of protein degradation pathways contributes to uncontrolled cell growth. In these cases KLHL13 interacts with proteins like p53 whose stability and degradation play significant roles in tumor suppression and progression.
We have tested this species and application combination and it works. It is covered by our product promise.
We have not tested this specific species and application combination in-house, but expect it will work. It is covered by our product promise.
This species and application combination has not been tested, but we predict it will work based on strong homology. However, this combination is not covered by our product promise.
We do not recommend this combination. It is not covered by our product promise.
We are dedicated to supporting your work with high quality reagents and we are here for you every step of the way should you need us.
In the unlikely event of one of our products not working as expected, you are covered by our product promise.
Full details and terms and conditions can be found here:
Terms & Conditions.
7.5% SDS-PAGE gel.
All lanes: Western blot - Anti-KLHL13 antibody - N-terminal (ab229150) at 1/1000 dilution
All lanes: HEK-293T (human epithelial cell line from embryonic kidney transformed with large T antigen) whole cell lysate at 30 µg
Developed using the ECL technique.
Predicted band size: 74 kDa, 78 kDa
Please note: All products are 'FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC OR THERAPEUTIC PROCEDURES'.
For licensing inquiries, please contact partnerships@abcam.com